{"id":"W3111386845","doi":"10.1111/ejh.13564","title":"One‐year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Hemoglobinuria; Adverse effect; Internal medicine; Anemia; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001031261,0.000337443,0.002704088,0.0002317078,0.00006371985,0.00001785409,0.0006844387,0.00009624324,0.001485924],"category_scores_gemma":[0.001221137,0.0002497604,0.0004650154,0.0001786911,0.0004211425,0.0001284077,0.0001347921,0.000550517,0.0001223382],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004176005,"about_ca_system_score_gemma":0.0002213938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002472852,"about_ca_topic_score_gemma":0.00001465107,"domain_scores_codex":[0.9919466,0.004876104,0.00227053,0.0003534814,0.0001605996,0.0003926818],"domain_scores_gemma":[0.9964469,0.0008718196,0.002017311,0.0003169969,0.0002282852,0.0001186515],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9862846,0.0008268099,0.001782302,0.0001112422,0.001373096,0.00166802,0.003257822,0.00001746852,0.00186301,0.0001314493,0.001373,0.001311145],"study_design_scores_gemma":[0.9881805,0.003532206,0.002043901,0.0006800313,0.0004048676,0.0005387717,0.0007871975,0.0000139181,0.002440515,0.00006290219,0.001047476,0.0002676681],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937615,0.00152195,0.0004846852,0.001675373,0.0006619606,0.001044846,0.00008155536,0.00002622366,0.0007418734],"genre_scores_gemma":[0.998825,0.00006997444,0.0006525439,0.0002108865,0.0001192085,0.000008911633,0.00004172031,0.0000430632,0.00002867741],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005063482,"threshold_uncertainty_score":0.9999955,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02286949683580114,"score_gpt":0.2583178488033262,"score_spread":0.2354483519675251,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}